Inventor · disambiguated record
De-Kuan Chang
Also filed as: CHANG DE-KUAN
9 granted patents·6 pending applications·25 citations·filing 2007–2025
83Inventor score
Files withDANA FARBER CANCER INST INC9WU HAN-CHUNG2BEIGENE SWITZERLAND GMBH1DANA-FARBER CANCER INSTITUTE INC1SANA BIOTECHNOLOGY INC1
Top patents by PatentIndex Score
15 records- 0187US11471490B2T cells surface-loaded with immunostimulatory fusion molecules and uses thereofTORQUE THERAPEUTICS INC·Filed 2018·Granted Oct 18, 2022·9 cites·30 claims
- 0286US10675349B2Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Jun 9, 2020·3 cites·25 claims
- 0384US12337034B2Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Granted Jun 24, 2025·0 cites·28 claims
- 0483US8394758B2Tumor-targeting peptides and uses thereofWU HAN-CHUNG·Filed 2009·Granted Mar 12, 2013·10 cites·20 claims
- 0581US2025339521A1Humanized cc chemokine receptor 4 (ccr4) antibodies and methods of use thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 0680US9441045B2Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2013·Granted Sep 13, 2016·2 cites·6 claims
- 0772US8415453B2Lung cancer-targeted peptides and applications thereofWU HAN-CHUNG·Filed 2007·Granted Apr 9, 2013·1 cites·13 claims
- 0870US11723973B2Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Aug 15, 2023·0 cites·32 claims
- 0964US2025082777A1Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and usesSANA BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 1063US2020261578A1Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereofDANA-FARBER CANCER INSTITUTE INC·Filed 2019·Application pending·0 cites
- 1160US2018094064A1Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 1260US2019276544A1Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 1358US9587028B2Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2015·Granted Mar 7, 2017·0 cites·6 claims
- 1449US10463732B2Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Nov 5, 2019·0 cites·12 claims
- 1549US2025290040A1Gamma delta t cell compositions and methods of useBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when De-Kuan Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →